Osteohematology: To be or Notch to be
- PMID: 37269472
- DOI: 10.1002/jcp.31042
Osteohematology: To be or Notch to be
Abstract
Osteohematology is an emerging research field that studies the crosstalk between hematopoietic and bone stromal cells, to elucidate the mechanisms of hematological and skeletal malignancies and diseases. The Notch is an evolutionary conserved developmental signaling pathway, with critical roles in embryonic development by controlling cell proliferation and differentiation. However, the Notch pathway is also critically involved in cancer initiation and progression, such as osteosarcoma, leukemia, and multiple myeloma. The Notch-mediated malignant cells dysregulate bone and bone marrow cells in the tumour microenvironment, resulting in disorders ranging from osteoporosis to bone marrow dysfunction. To date, the complex interplay of Notch signaling molecules in hematopoietic and bone stromal cells is still poorly understood. In this mini-review, we summarize the crosstalk between cells in bone and bone marrow and their influence under the Notch signaling pathway in physiological conditions and in tumour microenvironment.
Keywords: Notch; leukemia; multiple myeloma; osteoporosis; osteosarcoma.
© 2023 The Authors. Journal of Cellular Physiology published by Wiley Periodicals LLC.
References
REFERENCES
-
- Adams, G. B., Chabner, K. T., Alley, I. R., Olson, D. P., Szczepiorkowski, Z. M., Poznansky, M. C., Kos, C. H., Pollak, M. R., Brown, E. M., & Scadden, D. T. (2006). Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature, 439(7076), 599-603.
-
- Afshari, A., Shamdani, S., Uzan, G., Naserian, S., & Azarpira, N. (2020). Different approaches for transformation of mesenchymal stem cells into hepatocyte-like cells. Stem Cell Research & Therapy, 11(1), 54.
-
- Ahn, M. B. & Suh, B. K. (2020). Bone morbidity in pediatric acute lymphoblastic leukemia. Annals of Pediatric Endocrinology & Metabolism, 25(1), 1-9.
-
- Allen, F., & Maillard, I. (2021). Therapeutic targeting of notch signaling: from cancer to inflammatory disorders. Frontiers in Cell and Developmental Biology, 9, 649205.
-
- AlMuraikhi, N., Ali, D., Vishnubalaji, R., Manikandan, M., Atteya, M., Siyal, A., Alfayez, M., Aldahmash, A., Kassem, M., & Alajez, N. M. (2019). Notch signaling inhibition by LY411575 attenuates osteoblast differentiation and decreased ectopic bone formation capacity of human skeletal (Mesenchymal) stem cells. Stem Cells International, 2019, 1-12.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
